The company's asset efficiency, represented by a robust -8.812% return, is a testament to DelMar Pharmaceuticals, Inc.'s adeptness in optimizing resource deployment. DelMar Pharmaceuticals, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -5.728%. Furthermore, the proficiency of DelMar Pharmaceuticals, Inc. in capital utilization is underscored by a remarkable 7.052% return on capital employed.
Stock Prices
DelMar Pharmaceuticals, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.04, while its low point bottomed out at $0.04. This variance in figures offers investors a lucid insight into the roller-coaster ride that is DelMar Pharmaceuticals, Inc.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
